Cathelicidin (CAMP) is a critical antimicrobial peptide known for its protective roles in immune regulation, pathogen defense, and epithelial barrier maintenance. New research investigates how citrullination of CAMP, mediated by peptidyl arginine deiminase 4 (PAD4), exacerbates inflammatory bowel disease (IBD).
